Saturday 17 October 2026
Export ATHE’s income statement to Excel — free account
Alterity Therapeutics Limited - Sponsored ADR
ATHE Healthcare Biotechnology
Revenue growth for five consecutive years; insiders bought in the last twelve months.
2.62
0.10
−3.68%
Follow ATHE
| Jun '26 | Dec '25 | Jun '25 | Dec '24 | Older periods | |
|---|---|---|---|---|---|
Current Ratio |
14.52 | 21.98 | 12.98 | 3.84 |
+8 more quarters Free account |
Net Debt/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex/Depreciation |
0.00 | 0.00 | 0.00 | 0.00 | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
— | 0.00% | — | 0.00% | |
Free Cash Flow per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Cash per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Shareholders Equity per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow |
(15.29) | (6.97) | (7.42) | (5.44) | |
Working Capital |
28.96 | 35.61 | 27.42 | 5.02 | |
Capital Expenditures |
0.00 | — | 0.00 | — | |
Net Current Asset Value |
28.87 | 35.57 | 27.36 | 5.00 | |
| Other line items | |||||
Quick Ratio |
14.26 | 21.68 | 10.50 | 3.76 | |
Operating CF per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex per Share |
0.00 | — | 0.00 | — | |
Average Receivables |
3.94 | 4.20 | 4.19 | 4.18 | |
Average Payables |
2.20 | 1.71 | 2.02 | 2.13 | |
Average Assets |
21.92 | 25.92 | 24.10 | 14.41 | |
Average Common Equity |
19.02 | 23.56 | 21.41 | 11.78 | |
Capex to Sales |
0.00 | — | 0.00 | — |
Columns are period end dates